ArcticZymes Technologies ASA
B4V
Company Profile
Business description
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.
Contact
Sykehusveien 23
Tromso9294
NORT: +47 77648900
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
53
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,579.90 | 50.10 | 0.59% |
CAC 40 | 7,886.69 | 33.22 | 0.42% |
DAX 40 | 23,767.43 | 71.84 | 0.30% |
Dow JONES (US) | 42,654.74 | 331.99 | 0.78% |
FTSE 100 | 8,684.56 | 50.81 | 0.59% |
HKSE | 23,345.05 | 108.11 | -0.46% |
NASDAQ | 19,211.10 | 98.78 | 0.52% |
Nikkei 225 | 37,753.72 | 1.79 | -0.00% |
NZX 50 Index | 12,786.79 | 94.03 | -0.73% |
S&P 500 | 5,958.38 | 41.45 | 0.70% |
S&P/ASX 200 | 8,343.70 | 46.20 | 0.56% |
SSE Composite Index | 3,367.46 | 13.36 | -0.40% |